
Semiconductor sector still expected to grow
The coming rounds of development expenditure, particularly in Penang and Johor, are expected to reinforce Malaysia's competitiveness as multinational corporations continue to expand capacity in advanced packaging, front-end semiconductor processes and value-added EMS solutions.
Maybank Investment Bank Research (Maybank IB Research) noted that its recent visits to Penang and Johor reaffirmed Malaysia's role in the semiconductor and EMS supply chain despite near-term volatility from order deferrals and a weaker US dollar, which may impact its upcoming quarterly earnings.
'We stay 'neutral' on technology but favour front-end semiconductor exposure and players that focus on higher-value products,' the brokerage said.
Maybank IB added that its company visits took place before Malaysia's recent 19% tariff announcement, meaning 'near term impact visibility' remains limited until corporate earnings updates in the coming season.
It anticipates weaker quarterly results as firms grapple with tariff uncertainty and softer foreign exchange dynamics.
Yet, it maintained that easing tariff pressures or a potential US Federal Funds Rate cut in 2025 could spur a rotation back into growth counters.
Its top picks include Frontken Corp Bhd , with a target price of RM5.19; CPE EMS Bhd at RM1; and Aurelius Technologies Bhd at RM1.19.
Maybank IB Research observed that despite industry unease, stabilisation signs are emerging across the ecosystem.
'CPE EMS expects a rebound by late 2025, while Wentel Engineering Holdings Bhd is seeing stronger demand for security-screening equipment and is progressing with new product introductions for a front-end semiconductor client,' it noted.
Meanwhile, MClean Technologies Bhd anticipates sequential earnings improvement through 2025 on the back of higher hard disk drive orders and operational efficiencies.
Companies such as EG Industries Bhd , Supercomnet Technologies Bhd , Chemlite Innovation Bhd and Crest Group Bhd are also lining up new projects and recovery strategies, underscoring that growth momentum may accelerate from 2026.
BIMB Research, meanwhile, has also struck a cautious tone, maintaining its 'neutral' stance on the sector.
It flagged ongoing structural headwinds and unresolved tariff negotiations as core risks.
'There is no concrete conclusion of the semiconductor tariff, though we believe that 300% is not sensible.
'The outsourced semiconductor assembly and test business by nature, will remain anchored in Asia.
'As such, their near-term outlook hinges more on the ability to secure advanced packaging mandates rather than where tariff rates ultimately land, be it 25%, 100%, 300%, or never materialises at all,' the brokerage said.
BIMB Research also warned that investor sentiment could quickly reverse if tariffs are implemented at extreme levels.
'Investors have long braced for a semiconductor tariff, but consensus never pencilled in rates approaching triple digits.
'Furthermore, the artificial intelligence (AI) euphoria stemming from Nvidia-driven capital expenditure cycles, and hyperscale build-out has masked a good chunk of the headline risk.
'But for non-AI players like Malaysia, if the United States actually pulls the trigger at today's suggested levels, sentiment could snap back fast,' it explained.
Malaysia's prominent role as the United States' largest semiconductor exporter in 2024 makes the country particularly exposed.
BIMB Research pointed out: 'On paper, this implies Malaysia would need to absorb the highest nominal impact.
'However, this figure can be misleading, as it includes multinational corporations operating within Malaysia, many of which are possibly US-owned entities themselves.'
Nevertheless, listed firms such as Malaysian Pacific Industries Bhd and Unisem (M) Bhd face direct earnings risks given their higher US revenue exposure compared with peers like Dagang Nexchange Bhd .
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
16 hours ago
- The Star
Semiconductor sector still expected to grow
PETALING JAYA: Malaysia's technology sector is bracing for near-term challenges from tariffs and currency volatility, yet the country's role as a critical node in the global semiconductor and electronics manufacturing services (EMS) supply chain is unlikely to diminish. The coming rounds of development expenditure, particularly in Penang and Johor, are expected to reinforce Malaysia's competitiveness as multinational corporations continue to expand capacity in advanced packaging, front-end semiconductor processes and value-added EMS solutions. Maybank Investment Bank Research (Maybank IB Research) noted that its recent visits to Penang and Johor reaffirmed Malaysia's role in the semiconductor and EMS supply chain despite near-term volatility from order deferrals and a weaker US dollar, which may impact its upcoming quarterly earnings. 'We stay 'neutral' on technology but favour front-end semiconductor exposure and players that focus on higher-value products,' the brokerage said. Maybank IB added that its company visits took place before Malaysia's recent 19% tariff announcement, meaning 'near term impact visibility' remains limited until corporate earnings updates in the coming season. It anticipates weaker quarterly results as firms grapple with tariff uncertainty and softer foreign exchange dynamics. Yet, it maintained that easing tariff pressures or a potential US Federal Funds Rate cut in 2025 could spur a rotation back into growth counters. Its top picks include Frontken Corp Bhd , with a target price of RM5.19; CPE EMS Bhd at RM1; and Aurelius Technologies Bhd at RM1.19. Maybank IB Research observed that despite industry unease, stabilisation signs are emerging across the ecosystem. 'CPE EMS expects a rebound by late 2025, while Wentel Engineering Holdings Bhd is seeing stronger demand for security-screening equipment and is progressing with new product introductions for a front-end semiconductor client,' it noted. Meanwhile, MClean Technologies Bhd anticipates sequential earnings improvement through 2025 on the back of higher hard disk drive orders and operational efficiencies. Companies such as EG Industries Bhd , Supercomnet Technologies Bhd , Chemlite Innovation Bhd and Crest Group Bhd are also lining up new projects and recovery strategies, underscoring that growth momentum may accelerate from 2026. BIMB Research, meanwhile, has also struck a cautious tone, maintaining its 'neutral' stance on the sector. It flagged ongoing structural headwinds and unresolved tariff negotiations as core risks. 'There is no concrete conclusion of the semiconductor tariff, though we believe that 300% is not sensible. 'The outsourced semiconductor assembly and test business by nature, will remain anchored in Asia. 'As such, their near-term outlook hinges more on the ability to secure advanced packaging mandates rather than where tariff rates ultimately land, be it 25%, 100%, 300%, or never materialises at all,' the brokerage said. BIMB Research also warned that investor sentiment could quickly reverse if tariffs are implemented at extreme levels. 'Investors have long braced for a semiconductor tariff, but consensus never pencilled in rates approaching triple digits. 'Furthermore, the artificial intelligence (AI) euphoria stemming from Nvidia-driven capital expenditure cycles, and hyperscale build-out has masked a good chunk of the headline risk. 'But for non-AI players like Malaysia, if the United States actually pulls the trigger at today's suggested levels, sentiment could snap back fast,' it explained. Malaysia's prominent role as the United States' largest semiconductor exporter in 2024 makes the country particularly exposed. BIMB Research pointed out: 'On paper, this implies Malaysia would need to absorb the highest nominal impact. 'However, this figure can be misleading, as it includes multinational corporations operating within Malaysia, many of which are possibly US-owned entities themselves.' Nevertheless, listed firms such as Malaysian Pacific Industries Bhd and Unisem (M) Bhd face direct earnings risks given their higher US revenue exposure compared with peers like Dagang Nexchange Bhd .


The Star
17 hours ago
- The Star
Genting Plantations JV to have little early impact
BIMB Research described the capital commitment as 'sizeable' and therefore, execution risks exist. PETALING JAYA: Genting Plantations Bhd 's proposed venture into the vegetable-seeds business by partnering with a China firm is expected to have limited impact on near-term profits, owing to likely high upfront costs. Research houses such as BIMB Research and CIMB Research are 'neutral' on the venture. 'We expect contributions to come no earlier than financial year 2027 (FY27) as operations scale up,' BIMB Research said. Meanwhile, CIMB Research said: 'We believe the project is unlikely to be earnings-accretive in the near term given the high upfront capital expenditure required for technology acquisition and seed-breeding or research and developmentfacilities.' It pointed out that Genting Plantations' 60% share of the potential investment in the joint-venture (JV) is about RM315mil. Genting Plantations, via its indirect wholly owned unit ACGT Vegetable AgVentures (AVA), is planning a JV with Shouguang Vegetable Science & Technology (SVST), a Malaysian subsidiary of China's Shandong Shouguang Vegetable Industry Group (CSV). The JV will develop 70 acres of land in Kulai, Johor, into a centre of excellence for tropical vegetable crops. Two JV companies will be formed, one to spearhead seed breeding and technology transfer, and another to manage greenhouses, production, processing and trading. AVA will hold 60% in both entities, while SVST holds 40%. The completion is targeted by the first quarter of next year. In total, the capital commitment is about RM525mil by both parties. BIMB Research described the capital commitment as 'sizeable' and therefore, execution risks exist. 'But Genting Plantations' majority 60% stake and CSV's expertise and proven track record could mitigate downside,' the research house added. It also sees the JV as a strategic diversification beyond palm oil, strengthening Genting Plantations' environmental, social and governance credentials and aligning with Malaysia's food-security goals. 'Partnering CSV accelerates Genting Plantations' entry into high-value vegetable seeds and crops, a segment with growing domestic and export potential,' it added. CIMB Research noted that proceeds from Genting Plantations' recent disposal of agricultural land in Melaka to Scientex Bhd for RM333.8mil should be sufficient to fund the investment. Should the full amount be debt-funded, BIMB Research estimated that Genting Plantations' gearing would rise to about 0.34 times. This is still within comfortable levels and broadly in line with the plantation sector's average of around 0.4 times. 'We do not expect this JV to constrain Genting Plantations' dividend or capital expenditure plans for plantations.' BIMB Research has a 'buy' call on the stock, with a target price of RM6 a share. CIMB Research kept its 'hold' call with a target price of RM5.28.

The Star
6 days ago
- The Star
IHH eyes upside with Turkiye hospital acquisition
PETALING JAYA: Turkiye remains a growth engine for IHH Healthcare Bhd , underpinned by the strong occupancy rate of its hospitals there. BIMB Research in a report said Turkiye's largest hospital operator, Acibadem, which is majority-owned by IHH Healthcare Bhd, is operating at 75% occupancy. Revenue in the first quarter of financial year 2025 (1Q25) per inpatient admission rose 16% year-on-year on a constant currency basis to RM12,355, driven by a more acute case mix. 'Inpatient admissions totalled 44,311 in 1Q25, with foreign patients contributing 13% of revenue.' The research house said earnings before interest, taxes, depreciation and amortisation (Ebitda) for Turkiye came in at RM362mil, with a 300 basis points margin drop due to pre-operating costs from Acibadem Kartal and Vitosha, as well as Ramadan seasonality. Looking ahead, growth will be supported by the Bayındır acquisition. 'The Bayındır acquisition brings urban market exposure and potential procurement and operational synergies, and is supported by a pipeline to add 1,030 beds (circa additional 16%) by 2028, in line with rising demand for quality healthcare.' Acibadem announced earlier this week that it had agreed to buy an 80% stake in Bayındır Hospitals from Is Bankasi for US$55mil (RM232.2mil). BIMB Research said the acquisition offers Acibadem immediate capacity expansion, access to new catchment areas, and synergies in procurement and clinical standards, while also tapping into Turkiye's growing healthcare demand, supported by demographic trends and government initiatives. 'Retaining Turkiye Is Bankasi as a minority shareholder reduces political and operational risks while leveraging its local expertise. 'This transaction also strengthens IHH's diversification outside Malaysia, increasing its resilience against market-specific shocks.' BIMB Research said the financial impact to IHH in the near term is likely modest due to the relatively small scale of Bayındır's operations within the group. 'Integration risks remain, especially in aligning systems, regulatory compliance, and corporate culture. 'The deal comes amid continued Turkyish lira volatility, which may affect earnings translation. Nonetheless, the acquisition price appears reasonable given the asset scale and strategic location, though further disclosures on Bayındır's revenue, Ebitda and occupancy rates would help in refining our forecasts.' The research house is maintaining a 'buy' call on IHH with an unchanged target price of RM8.60. 'At this stage, we maintain our financial year 2025 (FY25) to FY26 forecasts pending completion and integration updates. 'The acquisition supports IHH's long-term growth profile but does not immediately alter earnings trajectory. 'Key monitors include post-merger performance, patient volumes, margin trends, and foreign exchange management. 'Given the group's strong balance sheet and execution track record in cross-border acquisitions, we view the move as a strategic positive but will reassess our target price upon receiving more financial details from management.'